The United States market has shown positive momentum, rising 1.6% over the last week and 12% over the past year, with earnings forecasted to grow by 14% annually. While 'penny stocks' might seem like a term from trading days gone by, they continue to represent opportunities in smaller or newer companies that can offer significant potential when backed by solid financials. This article explores three such penny stocks that demonstrate balance sheet strength and potential for growth, providing investors with a chance to uncover hidden value in quality companies.
Name | Share Price | Market Cap | Rewards & Risks |
Imperial Petroleum (IMPP) | $3.23 | $106.34M | ✅ 4 ⚠️ 1 View Analysis > |
New Horizon Aircraft (HOVR) | $1.37 | $42.06M | ✅ 4 ⚠️ 5 View Analysis > |
Waterdrop (WDH) | $1.38 | $509.94M | ✅ 4 ⚠️ 0 View Analysis > |
Greenland Technologies Holding (GTEC) | $2.09 | $37.66M | ✅ 2 ⚠️ 5 View Analysis > |
WM Technology (MAPS) | $1.06 | $176.59M | ✅ 4 ⚠️ 1 View Analysis > |
Perfect (PERF) | $1.82 | $187.4M | ✅ 4 ⚠️ 0 View Analysis > |
Tuniu (TOUR) | $0.9326 | $112.64M | ✅ 4 ⚠️ 0 View Analysis > |
Flexible Solutions International (FSI) | $4.39 | $54.64M | ✅ 1 ⚠️ 2 View Analysis > |
BAB (BABB) | $0.831825 | $5.9M | ✅ 2 ⚠️ 3 View Analysis > |
Lifetime Brands (LCUT) | $3.95 | $89.66M | ✅ 3 ⚠️ 2 View Analysis > |
Click here to see the full list of 714 stocks from our US Penny Stocks screener.
Let's review some notable picks from our screened stocks.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Performant Healthcare, Inc. offers audit, recovery, and analytics services in the United States and has a market cap of $252.15 million.
Operations: The company's revenue is primarily derived from its Business Services segment, which generated $128.92 million.
Market Cap: $252.15M
Performant Healthcare, Inc., with a market cap of US$252.15 million, has shown revenue growth in its Business Services segment, reporting US$33.27 million for Q1 2025 compared to US$27.33 million the previous year. Despite being unprofitable, the company has reduced losses over five years and maintains a strong cash position exceeding its total debt, offering a runway of over three years if current free cash flow levels persist. Although the management team is relatively new and insider selling has occurred recently, analysts agree on potential stock price appreciation by 113.4%.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Douglas Elliman Inc. operates in the United States, focusing on real estate services and property technology investments, with a market cap of approximately $235.16 million.
Operations: The company generates revenue primarily from its Real Estate Brokerage segment, which accounted for $1.05 billion.
Market Cap: $235.16M
Douglas Elliman Inc., with a market cap of US$235.16 million, is navigating the volatile penny stock landscape through strategic international expansion and potential merger discussions. The company recently launched Elliman International to tap into global luxury real estate markets, enhancing its service offerings without relying heavily on intermediaries. Despite being unprofitable, Douglas Elliman reported Q1 2025 revenue of US$253.4 million and reduced its net loss significantly compared to the previous year. While short-term assets cover liabilities, long-term liabilities remain uncovered by current assets, and share price volatility persists alongside a stable cash runway exceeding three years.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Zevia PBC develops, markets, sells, and distributes zero sugar beverages in the United States and Canada with a market cap of $187.04 million.
Operations: The company generates its revenue primarily from its Non-Alcoholic Beverages segment, amounting to $154.27 million.
Market Cap: $187.04M
Zevia PBC, with a market cap of US$187.04 million, operates in the zero sugar beverage sector and faces challenges typical for penny stocks. Despite being debt-free and having sufficient cash runway for over three years, Zevia remains unprofitable with increasing losses over the past five years. Recent earnings reported a Q1 2025 net loss of US$5.23 million on sales of US$38.02 million, slightly down from last year’s figures. While short-term assets exceed liabilities, significant insider selling raises concerns amid high share price volatility and an inexperienced management team averaging 1.3 years in tenure.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com